Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Instituto do Cancer do Estado de São Paulo
Vastra Gotaland Region
National Cancer Institute (NCI)
Turning Point Therapeutics, Inc.
Stanford University
Hoffmann-La Roche
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Nebraska
Ohio State University Comprehensive Cancer Center
Tanabe Pharma America, Inc.
Massive Bio, Inc.
Novelty Nobility, Inc.
Merck Sharp & Dohme LLC
Sichuan Baili Pharmaceutical Co., Ltd.
Circle Pharma
Jonsson Comprehensive Cancer Center
University of Pittsburgh
PharmaMar
Nuvation Bio Inc.
British Columbia Cancer Agency
Hoffmann-La Roche
Hutchmed
Nanjing First Hospital, Nanjing Medical University
EpicentRx, Inc.
National Cancer Institute (NCI)
Taproot Health
23andMe, Inc.
Hoffmann-La Roche
University of California, San Francisco
Peking Union Medical College Hospital
Tarveda Therapeutics
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
University of Maryland, Baltimore
Eli Lilly and Company
Stanford University
Novartis
Stanford University
Merck Sharp & Dohme LLC
Tel-Aviv Sourasky Medical Center